Welcome to the UPF Digital Repository

Dopamine D 2 receptor agonist binding kinetics-role of a conserved serine residue

Show simple item record

dc.contributor.author Ågren, Richard
dc.contributor.author Stepniewski, Tomasz Maciej, 1988-
dc.contributor.author Zeberg, Hugo
dc.contributor.author Selent, Jana
dc.contributor.author Sahlholm, Kristoffer
dc.date.accessioned 2021-05-07T07:06:18Z
dc.date.available 2021-05-07T07:06:18Z
dc.date.issued 2021
dc.identifier.citation Ågren R, Stepniewski TM, Zeberg H, Selent J, Sahlholm K. Dopamine D 2 receptor agonist binding kinetics-role of a conserved serine residue. Int J Mol Sci. 2021;22(8):4078. DOI: 10.3390/ijms22084078
dc.identifier.issn 1422-0067
dc.identifier.uri http://hdl.handle.net/10230/47347
dc.description.abstract The forward (kon) and reverse (koff) rate constants of drug-target interactions have important implications for therapeutic efficacy. Hence, time-resolved assays capable of measuring these binding rate constants may be informative to drug discovery efforts. Here, we used an ion channel activation assay to estimate the kons and koffs of four dopamine D2 receptor (D2R) agonists; dopamine (DA), p-tyramine, (R)- and (S)-5-OH-dipropylaminotetralin (DPAT). We further probed the role of the conserved serine S1935.42 by mutagenesis, taking advantage of the preferential interaction of (S)-, but not (R)-5-OH-DPAT with this residue. Results suggested similar koffs for the two 5-OH-DPAT enantiomers at wild-type (WT) D2R, both being slower than the koffs of DA and p-tyramine. Conversely, the kon of (S)-5-OH-DPAT was estimated to be higher than that of (R)-5-OH-DPAT, in agreement with the higher potency of the (S)-enantiomer. Furthermore, S1935.42A mutation lowered the kon of (S)-5-OH-DPAT and reduced the potency difference between the two 5-OH-DPAT enantiomers. Kinetic Kds derived from the koff and kon estimates correlated well with EC50 values for all four compounds across four orders of magnitude, strengthening the notion that our assay captured meaningful information about binding kinetics. The approach presented here may thus prove valuable for characterizing D2R agonist candidate drugs.
dc.format.mimetype application/pdf
dc.language.iso eng
dc.publisher MDPI
dc.relation.ispartof Int J Mol Sci. 2021;22(8):4078
dc.rights © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
dc.rights.uri http://creativecommons.org/licenses/by/4.0/
dc.title Dopamine D 2 receptor agonist binding kinetics-role of a conserved serine residue
dc.type info:eu-repo/semantics/article
dc.identifier.doi http://dx.doi.org/10.3390/ijms22084078
dc.subject.keyword G protein-coupled receptor
dc.subject.keyword Xenopus oocytes
dc.subject.keyword Aminotetralins
dc.subject.keyword Electrophysiology
dc.subject.keyword Molecular dynamics simulation
dc.subject.keyword Phenethylamines
dc.subject.keyword Voltage-clamp
dc.rights.accessRights info:eu-repo/semantics/openAccess
dc.type.version info:eu-repo/semantics/publishedVersion


This item appears in the following Collection(s)

Show simple item record

Search DSpace

Advanced Search


My Account


Compliant to Partaking